Abaris Biotech.Opportunities A USD/ LU2210105313 /
| NAV21/05/2024 | Chg.+0.0300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 62.5500USD | +0.05% | reinvestment | Equity Worldwide | Hauck & Aufhäuser ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 6.95 | -1.98 | -12.28 | 4.77 | -8.19 | 6.42 | -8.04 | 3.78 | -5.47 | 1.72 | -15.13 | 0.42 | -26.38% |
| 2022 | -25.72 | 3.45 | 3.48 | -20.26 | -16.00 | 6.47 | 11.18 | 0.90 | -6.68 | -0.79 | -5.98 | 1.78 | -43.64% |
| 2023 | 15.67 | -7.95 | -9.99 | 4.17 | 4.20 | -1.41 | 3.73 | -8.69 | -10.28 | -17.12 | 22.41 | 32.47 | +17.13% |
| 2024 | -1.75 | 38.41 | -6.39 | -13.54 | 6.02 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 42.45% | 43.78% | 39.46% | 42.34% | -% |
| Sharpe ratio | 1.08 | 3.47 | 0.70 | -0.41 | - |
| Best month | +38.41% | +38.41% | +38.41% | +38.41% | - |
| Worst month | -13.54% | -13.54% | -17.12% | -25.72% | - |
| Maximum loss | -22.94% | -22.94% | -37.40% | -69.48% | - |
| Outperformance | -12.71% | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Abaris Biotech.Opportunities A C... | reinvestment | 62.7300 | +32.04% | -34.93% | |
| Abaris Biotech.Opportunities A E... | reinvestment | 68.6500 | +30.49% | -26.91% | |
| Abaris Biotech.Opportunities A U... | reinvestment | 62.5500 | +31.27% | -35.21% |
Performance
| YTD | +16.68% | ||
|---|---|---|---|
| 6 Months | +59.36% | ||
| 1 Year | +31.27% | ||
| 3 Years | -35.21% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | -43.51% | ||
| Year | |||
| 2023 | +17.13% | ||
| 2022 | -43.64% | ||
| 2021 | -26.38% | ||
